InvestSMART

Biotron Limited (ASX: BIT) - Announcements

- Current share price for BIT : $0.002

ASX company news and announcements for Biotron Limited (BIT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Biotron Limited (BIT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Biotron Limited (BIT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Biotron Limited (BIT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 Application for quotation of securities - BIT 26 Oct 2023 11:17AM $0.086 $0.002 fallen by 97.67%
$6 Presentation to Investors 24 Oct 2023 9:40AM $0.080 $0.002 fallen by 97.50%
$6 Annual Report/Notice of Annual General Meeting/Proxy Form 20 Oct 2023 9:42AM $0.088 $0.002 fallen by 97.73%
$6 Application for quotation of securities - BIT 10 Oct 2023 2:05PM $0.099 $0.002 fallen by 97.98%
$6 Response to ASX Price Query 29 Sep 2023 11:45AM $0.068 $0.002 fallen by 97.06%
$6 Letter to Shareholders 26 Sep 2023 9:43AM $0.031 $0.002 fallen by 93.55%
$6 Response to ASX Price Query 11 Sep 2023 2:51PM $0.038 $0.002 fallen by 94.74%
$6 Appendix 4G 25 Aug 2023 5:01PM $0.031 $0.002 fallen by 93.55%
$6 Corporate Governance Statement 25 Aug 2023 5:01PM $0.031 $0.002 fallen by 93.55%
$6 Full Year Statutory Accounts and Appendix 4E 25 Aug 2023 5:01PM $0.031 $0.002 fallen by 93.55%
$6 COMPLETION OF PHASE 2 COVID CLINICAL TRIAL 16 Aug 2023 9:52AM $0.030 $0.002 fallen by 93.33%
$6 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jul 2023 9:09AM $0.032 $0.002 fallen by 93.75%
$6 Second Site Approved for Phase 2 Covid-19 Trial 12 May 2023 10:16AM $0.028 $0.002 fallen by 92.86%
$6 Commencement Phase 2 Covid-19 Clinical Trial 4 May 2023 9:15AM $0.029 $0.002 fallen by 93.10%
$6 Quarterly Activities/Appendix 4C Cash Flow Report 27 Apr 2023 11:00AM $0.028 $0.002 fallen by 92.86%
$6 Cleansing Notice 22 Mar 2023 2:42PM $0.026 $0.002 fallen by 92.31%
$6 Application for quotation of securities - BIT 22 Mar 2023 2:39PM $0.026 $0.002 fallen by 92.31%
$6 Completion of Phase 2 HIV-1 Clinical Trials 9 Mar 2023 9:59AM $0.027 $0.002 fallen by 92.59%
$6 International Presentation of BIT225 COVID-19 Data 21 Feb 2023 10:08AM $0.028 $0.002 fallen by 92.86%
$6 Half Yearly Report and Accounts 17 Feb 2023 12:50PM $0.030 $0.002 fallen by 93.33%
$6 Notification of cessation of securities - BIT 1 Feb 2023 5:35PM $0.032 $0.002 fallen by 93.75%
$6 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2023 9:33AM $0.029 $0.002 fallen by 93.10%
$6 CLEANSING NOTICE 25 Jan 2023 1:42PM $0.029 $0.002 fallen by 93.10%
$6 Application for quotation of securities - BIT 25 Jan 2023 1:29PM $0.029 $0.002 fallen by 93.10%
$6 Change of Director's Interest Notice 29 Nov 2022 1:08PM $0.028 $0.002 fallen by 92.86%

151 - 175 of 594 results

Page 7 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.